title: Low-dose coronary CT angiography with prospective ECG triggering: validation of a contrast material protocol adapted to body mass index.
abstract: OBJECTIVE
  The aim of the study was to validate a body mass index (BMI)-adapted contrast material protocol to compensate for the effect of BMI on coronary attenuation during low-dose coronary CT angiography with prospective ECG triggering.
  
  
  METHODS
  One hundred forty patients underwent prospectively ECG-triggered coronary CT angiography for clinical indications. The following BMI-adapted contrast material protocol was used for imaging of 70 consecutively registered patients: BMI < 17.5, 50 mL contrast material at 4.0 mL/s; 17.5-22.4, 55 mL at 4.0 mL/s; 22.5-24.9, 65 mL at 4.0 mL/s; 25.0-27.4, 80 mL at 4.5 mL/s; 27.5-29.9, 80 mL at 5.0 mL/s; 30.0-34.9, 85 mL at 5.0 mL/s; 35.0-40.0, 95 mL at 5.0 mL/s; > 40, 105 mL at 5.0 mL/s. Seventy patients matched for BMI who had previously undergone routine coronary CT angiography with a fixed contrast material dosage of 80 mL at 5 mL/s served as the reference group. Vessel attenuation in the left main and proximal right coronary arteries was measured and correlated with BMI, and the results in the two protocol groups were compared.
  
  
  RESULTS
  The groups were well matched for BMI. The mean BMI in the nonadapted protocol group was 26.5 +/- 4.0 (standard deviation) (range, 18.9-36.5), and that in the BMI-adapted protocol group was 26.7 +/- 4.2 (range, 18.2-37.2) (p not significant). The mean amount of contrast material used was smaller in the BMI-adapted group (73.9 +/- 11.2 vs 80.0 +/- 0 mL; p < 0.01). Mean coronary artery attenuation did not differ significantly between the two groups (386 +/- 102 HU vs 385 +/- 64 HU; p not significant). Without BMI adaptation, coronary attenuation correlated strongly with BMI (r = -0.63; p < 0.001). With the BMI-adapted protocol, however, there was no correlation between BMI and coronary attenuation (r = -0.24; p not significant).
  
  
  CONCLUSIONS
  We validated a BMI-adapted contrast material protocol that results in adequate coronary vessel attenuation independent of individual BMI despite a significant reduction in overall amount of contrast material used.
authors.affiliation: Department of Medical Radiology and Cardiovascular Center, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland.
authors.forename: Lars
authors.initials: L
authors.lastname: Husmann
authors.forename: Bernhard A
authors.initials: BA
authors.lastname: Herzog
authors.forename: Nina
authors.initials: N
authors.lastname: Burkhard
authors.forename: Ines
authors.initials: I
authors.lastname: Valenta
authors.forename: Irene A
authors.initials: IA
authors.lastname: Burger
authors.forename: Oliver
authors.initials: O
authors.lastname: Gaemperli
authors.forename: Philipp A
authors.initials: PA
authors.lastname: Kaufmann
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015992:Body Mass Index; D003287:Contrast Media / Q000008:administration & dosage*; D017023:Coronary Angiography / Q000379:methods*; D003327:Coronary Disease / Q000000981:diagnostic imaging*; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011829:Radiation Dosage; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D014057:Tomography, X-Ray Computed; D014283:Triiodobenzoic Acids / Q000008:administration & dosage*
chemical_list: D003287:Contrast Media; D014283:Triiodobenzoic Acids; C044834:iodixanol